comparemela.com

Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE's Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE's Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom ,United States ,Australia ,Michael Amoroso ,Jamesm Wilson ,University Of Pennsylvania Gene Therapy Program ,Linkedin ,Nasdaq ,Drug Administration ,European Commission ,Precision Biosciences Inc ,Precision Biosciences ,Fast Track ,Ornithine Transcarbamylase ,Rare Pediatric Disease ,Orphan Drug ,Chief Executive Officer ,Gene Therapy Program ,Private Securities Litigation Reform Act ,Annual Report ,

comparemela.com © 2020. All Rights Reserved.